BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35565216)

  • 21. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
    Karlo CA; Di Paolo PL; Chaim J; Hakimi AA; Ostrovnaya I; Russo P; Hricak H; Motzer R; Hsieh JJ; Akin O
    Radiology; 2014 Feb; 270(2):464-71. PubMed ID: 24029645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression.
    Marigliano C; Badia S; Bellini D; Rengo M; Caruso D; Tito C; Miglietta S; Palleschi G; Pastore AL; Carbone A; Fazi F; Petrozza V; Laghi A
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819878458. PubMed ID: 31564221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
    Fernández-Pello S; Hofmann F; Tahbaz R; Marconi L; Lam TB; Albiges L; Bensalah K; Canfield SE; Dabestani S; Giles RH; Hora M; Kuczyk MA; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A
    Eur Urol; 2017 Mar; 71(3):426-436. PubMed ID: 27939075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways.
    Lin P; Lin YQ; Gao RZ; Wen R; Qin H; He Y; Yang H
    Transl Oncol; 2021 Jul; 14(7):101078. PubMed ID: 33862522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.
    Li ZC; Zhai G; Zhang J; Wang Z; Liu G; Wu GY; Liang D; Zheng H
    Eur Radiol; 2019 Aug; 29(8):3996-4007. PubMed ID: 30523454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiogenomics study to predict the nuclear grade of renal clear cell carcinoma.
    He XM; Zhao JX; He DL; Ren JL; Zhao LP; Huang G
    Eur J Radiol Open; 2023; 10():100476. PubMed ID: 36793772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel tumor microenvironment-related radiogenomics model for prognosis prediction in hepatocellular carcinoma.
    Wang Y; Gao B; Xia C; Peng X; Liu H; Wu S
    Quant Imaging Med Surg; 2023 Sep; 13(9):5803-5814. PubMed ID: 37711809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways.
    Zhao Y; Liu G; Sun Q; Zhai G; Wu G; Li ZC
    Eur Radiol; 2021 Jul; 31(7):5032-5040. PubMed ID: 33439312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of an Integrative Prognostic Model of Radiogenomics Features With Underlying Gene Expression Patterns in Clear Cell Renal Cell Carcinoma.
    Huang Y; Zeng H; Chen L; Luo Y; Ma X; Zhao Y
    Front Oncol; 2021; 11():640881. PubMed ID: 33763374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.
    Kocak B; Durmaz ES; Kaya OK; Kilickesmez O
    Acta Radiol; 2020 Jun; 61(6):856-864. PubMed ID: 31635476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.
    Demirjian NL; Varghese BA; Cen SY; Hwang DH; Aron M; Siddiqui I; Fields BKK; Lei X; Yap FY; Rivas M; Reddy SS; Zahoor H; Liu DH; Desai M; Rhie SK; Gill IS; Duddalwar V
    Eur Radiol; 2022 Apr; 32(4):2552-2563. PubMed ID: 34757449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of STAT3 protein as a prognostic factor in the clear cell renal carcinoma. Systematic review.
    Lorente D; Trilla E; Meseguer A; Arevalo J; Nemours S; Planas J; Placer J; Celma A; Salvador C; Regis L; Schwartzmann I; Morote J
    Actas Urol Esp (Engl Ed); 2019 Apr; 43(3):118-123. PubMed ID: 30466966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology.
    Shui L; Ren H; Yang X; Li J; Chen Z; Yi C; Zhu H; Shui P
    Front Oncol; 2020; 10():570465. PubMed ID: 33575207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiogenomics in personalized management of lung cancer patients: Where are we?
    Araujo-Filho JAB; Mayoral M; Horvat N; Santini FC; Gibbs P; Ginsberg MS
    Clin Imaging; 2022 Apr; 84():54-60. PubMed ID: 35144039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.
    Jansen RW; van Amstel P; Martens RM; Kooi IE; Wesseling P; de Langen AJ; Menke-Van der Houven van Oordt CW; Jansen BHE; Moll AC; Dorsman JC; Castelijns JA; de Graaf P; de Jong MC
    Oncotarget; 2018 Apr; 9(28):20134-20155. PubMed ID: 29732009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiogenomics in prostate cancer evaluation.
    Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
    Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study.
    Cianflone F; Lazarevic D; Palmisano A; Fallara G; Larcher A; Freschi M; Dell'Antonio G; Scotti GM; Morelli MJ; Ferrara AM; Trevisani F; Cinque A; Esposito A; Briganti A; Tacchetti C; Doglioni C; Del Maschio A; de Cobelli F; Bertini R; Salonia A; Montorsi F; Tonon G; Capitanio U
    Transl Androl Urol; 2022 Feb; 11(2):149-158. PubMed ID: 35280651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-Enhanced Computed Tomography-Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer.
    Liu H; Wang Y; Liu Y; Lin D; Zhang C; Zhao Y; Chen L; Li Y; Yuan J; Chen Z; Yu J; Kong W; Chen T
    Front Oncol; 2022; 12():882786. PubMed ID: 35814414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT-based machine learning model to predict the Fuhrman nuclear grade of clear cell renal cell carcinoma.
    Lin F; Cui EM; Lei Y; Luo LP
    Abdom Radiol (NY); 2019 Jul; 44(7):2528-2534. PubMed ID: 30919041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.